Evidence map›Paper›PMID 38886051›Full record

ArticleTobacco control2025

Tobacco endgame goals and measures in Europe: current status and future directions.

Hanna Ollila, Otto Ruokolainen, Tiina Laatikainen, Helena Koprivnikar, JATC-2 WP9 co-authors

Abstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hanna OllilaDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland hanna.ollila@thl.fi.ORCID 0000-0002-8814-1021
Otto RuokolainenDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0001-9601-7330
Tiina LaatikainenDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-6614-4782
Helena KoprivnikarNational Institute of Public Health of the Republic of Slovenia, Ljubljana, Slovenia.ORCID 0000-0003-3339-8441
JATC-2 WP9 co-authors

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Union (EU) aims for a tobacco use prevalence of less than 5% by 2040 with its Tobacco-Free Generation goal, aligning with the tobacco endgame approach. In the Joint Action on Tobacco Control 2 (JATC-2) -project, we examined adopted and planned endgame goals and measures as well as preparedness to counter tobacco industry interference in the process. We surveyed key informants in 24 out of 50 countries in the WHO European Region (19 of the 27 EU Member States, MS). Altogether, eight countries (7 EU MS) had official governmental endgame goals, and an additional six EU MS had similar proposals from government, civil society or research entities. Movement towards tobacco endgame was most evident in retail-oriented and consumer-oriented policies. These include restricting the sales of tobacco and related products and raising the age limit above 18 years. Product standards were used especially to regulate flavours but no measures to substantially reduce addictiveness were reported. Market-oriented measures that tap into industry profits were predominantly missing, and countries often lacked concrete tools to prevent industry interference. Respondents' concerns around tobacco endgame were related to high smoking prevalence in some population groups, non-combustible and new nicotine products, cross-border marketing, political will, challenges with the existing regulations and industry interference. Results indicate both momentum and challenges in adopting and disseminating measures that facilitate achieving tobacco endgame goals. The EU goal can be used to advocate for national endgame goals and measures, and for the strengthened implementation of the WHO Framework Convention on Tobacco Control.

Indexed as

SmokingSmoking CessationSmoking PreventionTobacco IndustryTobacco ProductsCommerceEuropeEuropean UnionGoalsHumansMarketingPrevalenceEnd gamePreventionPublic policyTobacco industry

Identifiers

PMID38886051
PMCPMC12772598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.